chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bad diarrhea the day of the vaccination.; Fever of 101.2 degrees Farenheight.; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Bad diarrhea the day of the vaccination.) and PYREXIA (Fever of 101.2 degrees Farenheight.) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (Bad diarrhea the day of the vaccination.) and PYREXIA (Fever of 101.2 degrees Farenheight.). On 28-Feb-2021, DIARRHOEA (Bad diarrhea the day of the vaccination.) had resolved. At the time of the report, PYREXIA (Fever of 101.2 degrees Farenheight.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment informations were reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  A 61-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: CARVEDILOL; AMLODIPINE; ATORVASTATIN; LOSARTAN; HYDROCHLOROTHIAZIDE; SERTRALINE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the reported information ,a causal relationship between the event COVID19 and suspected drug cannot be excluded.
Pt was a direct admit from Hospital and was admitted for shortness of breath and found to have a UTI with sepsis.  She was tested for COVID prior to transfer and found to  be COVID positive.
Vaccine was administered in the patient's left arm. The actual vaccine liquid content trickled down her arm. The hub (where syringe and needle meet) was loose. Patient was administered another dose.
Some skin rashes as reaction when there is an allergen; Rash/They red bumps and itches; Rash/They red bumps and itches; This is a spontaneous report from a contactable other hcp.  A 49-years-old female patient started to receive  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EL0140), intramuscular (arm left) on 28Dec2020 12:00 at single dose (dose 1) for COVID-19 immunization. Medical history included psoriasis from an unknown date and allergies to medications, food, or other products (unspecified). The patient was taking unspecified concomitant medications including a vaccine within 2 weeks. Patient did not receive other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 with unknown results. On 29Dec2020 04:00, the patient had some skin rashes as a reaction when there is an allergen. After the vaccines, she has been having occasional rashes that pops at different places. They were red bumps and itches. She stated she needed to keep antihistamines CLARITIN/BENADRYL on the clock. Event outcome was not recovered. The patient underwent lab tests and procedures which included COVID test (Nasal swab): negative on 24Nov2020. Event outcome was not recovered. Patient considered the events as non-serious.
Palpitation, shortness of breath, dizzy, nausea, headache, pain on injection site
Information has been received from a pharmacist referring to multiple unspecified patients of unknown age and gender. Information about patients' concurrent conditions and medical history was not reported. The pharmacist reported that on unknown dates the patients "might" have received doses of improperly stored VARIVAX (Merck) (lot#, dose and route were unknown). Concomitant medications were not provided. No adverse effects were reported. This is one of three reports received from the same reporter (other linked case # 1511USA009275 and 1511USA009327). Additional information has been requested.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender who on 25-JUN-2015 was vaccinated with a dose of GARDASIL lot # K006960 (route and dose were not provided) was exposed to temperatures outside of the recommended range during 63 hours excursion. No adverse effects had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
I Developed a hive  raised area about size of 3 quarters with rash area extending around the raised area. Itchy Date of rash was 8 days after the 1st dose of vaccine Vaccine date 01/14/2021 Rash appeared on 01/22/2021 around 12:00 pm
After 2 days receiving the shot - woke up with severe painful swelling in the outer right chest and under armpit area. Swelling continued for multiple days and as of this time is still present but no longer painful.
This spontaneous report was received from a Registered Nurse concerning a patient of unknown age and gender. Patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 08-DEC-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (Lot #M038359 and expiration date: 13-MAY-2018; however, dose and route of administration were not reported) for prophylaxis. The temperature was 35.2 F, time frame was unknown, and there was no previous temperature excursion. The call was due to a data logger. No adverse symptoms reported and no further information was provided. There was no product quality complaint involved. Additional information has been requested.
Symptoms: Fever, chills, headache, nausea, muscle aches, anorexia  -these symptoms were worse than any sickness I?ve had and were stronger than the ones I felt following my first dose of the Pfizer Covid vaccine. It should also be noted that these symptoms far exceeded the severity of the ones I experienced when I had Covid 19 more than a year ago. Treatment: 1000mg Tylenol which allowed for a couple of hours of sleep. Awoke with a low grade fever despite the Tylenol
Swollen (R) thigh. 6-8 cm of erythema with 3/4 cm of induration.
Expired Havrix administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 28-year-old female patient who received HAV (Havrix) (batch number H4H53, expiry date 30th January 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 31st January 2023, the patient received the 1st dose of Havrix and Havrix Pre-Filled Syringe Device. On 31st January 2023, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's Comments: Medical Assistant reported that a female 28 years old patient received an expired dose of Havrix on day of reporting. Initials for patient not provided when asked. The reporter consented to follow up via email.  The Vaccine Administration Facility is the same as Primary Reporter. Additional Supportive Information: The patient received Havrix, which was already expired.
left arm was red, painful and swollen when patient awoke the day after receiving her vaccines.  The redness,pain & edema lasted about 3 days. The edema & pain resolved after 3 days but an erythemetous somewhat dry patch of skin (4 X 6 cm) over the left deltoid was apparent on 2/17 when patient presented for a well child exam.  Pt denied pain, stating "it just itches".  Grandfather reports patient never had swelling anywhere but the arm.  She did not have any respiratory or abdominal symptoms with the reaction.
A non-serious spontaneous report of Influenza A has been received from the patient's parent/registered nurse concerning a five-year-old female patient, subsequent to receiving FLUMIST. The patient's medical history and concomitant medications were not reported. On 09-Oct-2009, patient received FLUMIST. On 19-Oct-2009, the patient experienced a fever of 101.8 F, terrible cough, and headache. She tested positive for Influenza A. The outcome for the reported adverse event was not reported.
The patient was on her way back to nursing school class and noticed half way there her throat was becoming itchy and she was sob - her arm was itching tremendously so she went to the ER - she received some Benadryl, steroid and Zantac iv - she was seen by dr at the ER.
2nd dose was EW0162, 4/15/2021;~3 wk after first dose had episode of epigastric pain, malaise, light headedness for ~3 hrs. Got 2nd dose ~4 days later.  Then 5/14, had ER visit for above epigastric pain, malaise, lightheadedness  then 5/22-5/25; had ER visit after similar episode but also developed whole body hives, low blood pressure event, suspected to be mastocytosis, however bone marrow biopsy later suggested against this. 5/31 similar episode started, required epi at home and led to another 3 day hospitalization.
I got the vaccine in Feb in Oct I noticed I had problems using a straw which grew Oct 6. 2021 Called healthcare asked if I could puff out my cheeks with air. Around 10:30 Pm on the 6th of October I went to the ER of scan was conducted with and without contrast, chewable aspirin was given 81 mg no evidence of stroke, MRI was done the next day consulted with neurologist  a diagnosis of Bell's palsy given. Treated with antiviral medication. Resolved 3-4 weeks later.
fever; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever on an unspecified date. Patient stated that she has a fever as a side effect after getting the first dose of the Pfizer Covid 19 vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
20 yo male with S and S (B) hand numbness, atrophy, decreased coordination after receipt of adenovirus (lot# 34600212 BRR), hep A (#9M57P SKB), IIV (#U55306), IPV (K1694-1), MCV4P (U580AA CSL), Tdap (AH4LF SKB), varicella (L050957 Merck) vaccines. Per neuro notes symptoms included numbness and weakness of his hands, 1 week after vaccine receipt; progressing to feet two weeks later (week 3). Symptoms were constant, difficulty with fine motor skills, grasp, (R) foot drop, left foot weakness. Vaccine receipt was 20 May 2016, PT note on 31 May notes thenar and hypothenar atrophy and Ape hand appearance (intrinsic weakness). He was admitted on 27 June 16 and discharged 03 July 16. He received IVIG for presumed GBS with symptom improvement. He did not have an LP. EMG-NCS. Abnormal study with electrical evidence of slowing of multiple motor and sensory nerves most consistent with the diagnosis of peripheral polyneuropathy and most likely a diffuse demyelinating process like Guillain-Barre Syndrome. No evidence any specific peripheral nerve impingement although there was extra slowing of the median nerve. There is no evidence of radiculopathy on needle exam. There was no evidence of myopathy on needle exam. Patient was referred for vaccine causality. Genetic testing for PMP22 demonstrated deletion confirming HNPP diagnosis.
Patient presented with stroke-like symptoms and headache. Right-sided leg numbness that ascended to right arm and eventually face with facial droop and slurred speech.
Narrative: 71 yo male with PMHx of HCC (liver cancer), spinal stenosis of lumbar region, Mood disorder, PTSD, recurrent major depression in partial remission, COPD, HLD, CAD, DM, H/o ETOH dependence, esophageal varices due to cirrhosis, HCV, who was enrolled in home hospice, presented to the ED via EMS on 09/30/21 d/t melena and weakness after a fall. Patient was recently admitted to MC from d/t 9/17 to 9/18/21 d/t Decompensated Cirrhosis due to HCC. He was discharged home on 9/18/21 with home hospice. Pt died at home in hospice care on 10/01/2021. Death was caused by: HCC stage IV. Pt had receive 3 covid vaccines on 2/2/21, 3/2/21, 8/31/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and length of time between date of vaccines and date of death.
Developed wamth, redness, swelling and itching 3" x 5" around shot site. No resp. prob. nl pulse and HR; no sweating.
Patient stated that within 45 min of receiving the vaccine she felt very fatigued, and itchy all over. She also stated that the left side of her face felt numb. She did not seek out treatment and the symptoms resolved on their own.
The pt experienced localized redness, swelling to the left arm and was treated with analgesics and warm compresses.
Reports developed half dollar sized whelp, red, hot and bruised 5 inches below injection site on 1/6/21. Rash on chest started, took Benedryl 25mg PO, woke up 1/7/21 took another Benedryl 25 mg PO and started with itching on torso and back.  Reported had some nausea evening of 1/6/21 took Pepto Bismal. Instructed to seek further medical evaluation with rash/itching continuing to spread.
Two days after my first dose I have what is presenting itself as impetigo. It lasted nine days and I did nothing to make it go away. The second time it came 9 days after my second dose, also presenting itself as impetigo. I?m a mother of a 9 yo, 6 yo and 1 yo, none of them have had any impetigo signs or symptoms in the last six weeks. Antibiotics makes it go away but within 48 hours of stopping antibiotics it returns.
Pt who had johson and Johnson vaccine on 4/5/21 after which has developed some headache which is now resolved and lower limb pin and needle sensation on both feet for the last 6 days, denies any vision change, sob , chest pain , limb swelling or pain . has not tried taking any medication for this symptoms  PARESTHESIA- LOWER LIMBS BILAT. ? cause but still still developed after J&J vaccine, for now we will treat with vitamin B complex, patient advised to call with any episode of severe headache difficulty in breathing, chest discomfort or swelling/pain  of the lower extremities
APPROX ONE WEEK LATER DEVELOPED FEVER OF 102.6  WE LOWERED IT WITH MOTRIN  FEVER PERSISTED FOR 3 DAYS APPROX.  AND SHE DEVELOPED A GENERALIZED RASH/HIVES ON HER BODY WHICH LASTED FOR 4 DAYS APPROX.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "recovering" and all described as "COVID-19". Therapeutic measures were taken as a result of suspected covid-19, drug ineffective.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Upper right arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Upper right arm soreness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Upper right arm soreness). At the time of the report, VACCINATION SITE PAIN (Upper right arm soreness) outcome was unknown. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications reported by reporter. Treatment medication not reported.
At approximately 9:15 am on 10/12/04 the flu vaccine was administered.  Patient states that as soon as she recieved the injection her right eye began to burn.  She did not notify the nurse because she did not realize it was due to the injection.  Her Grandfather took her to school after that.  During the school day the tissue around the right eye became red and began to swell.  When I came home from work at 6pm her eyelid above the eye was extremely swollen.  The tissue below the eye was also extremely swollen and dark.  I gave her 25mg of Benadryl at 6pm and another 25mg at 10pm.  The next morning,(10-13-04)the swelling around her eye came down but the tissue was still slightly swollen.  Underneath her eye the tissue became bruised.  I took her in to her Pediatrician to have the reaction documented in her chart.  As of today 10-14-04 the swelling is almost completely gone however the tissue underneath the right eye has a bruise approximately 2cm long and 0.5cm wide.
had my first dose of my vaccine on March 17th and this past Saturday I was positive for Covid 19; she had a fever Friday night; she was very tired; she had a 99.4 degree temperature that night; This is a spontaneous report from a contactable consumer or other Non-health care professional via Pfizer sponsored program.  A 64-year-old female patient received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Expiry Date: unknown, Batch/Lot number: EN6206), via an unspecified route of administration, in left arm on 17Mar2021 10:00 AM (at the age of 64-year-old) as dose 1, single for covid-19 immunization. The patient medical history was not reported and patient did not have any illness at time of vaccination. Family Medical History reported that She was exposed to her 3 grandkids, who all tested positive for the COVID-19 Virus. The patient's concomitant medications were not reported. patient had not received any other vaccines priorly within 4 weeks of vaccination. Patient stated had her first COVID-19 Vaccine, she tested PCR test and resulted as positive for the COVID-19 Virus on 27Mar2021. She said she was in contact with all 3 of her grandkids, and all 3 of her grandkids were positive for the COVID-19 Virus. She said she went to her grandkids house on 21Mar2021. She said she started to have symptoms before she knew her grandkids had the COVID-19 Virus. she said on 25Mar2021 she was very tired and had a 99.4 degree temperature that night. She said that Friday, 26Mar2021 she found out her granddaughter was positive for the COVID-19 Virus. She said that night, she had a fever on 26Mar2021. She said she went on Saturday, 27Mar2021 to be tested for the COVID-19 Virus, and found out on late Sunday night, 28Mar2021 that she was positive for the COVID-19 Virus. She said she was scheduled to get her second COVID-19 Vaccine on 08Apr2021 would be 2 weeks after she had her minor COVID-19 Virus symptoms. She said she wanted to know if she should still get the second vaccine dose, since she had tested positive for the COVID-19 Virus. It was reported she took 2 Extra Strength Tylenol 500mg caplets twice (6 hours apart, Lot Number: AAA103, Expiration Date: Sep2024) on Friday, and then she took another dose right before she had her COVID-19 Virus testing on Saturday, 27Mar2021. Patient was not attended emergency Room, or Physician Office on experiencing events. Reporter wants to know if you get the first dose of the vaccine then tested positive for COVID-19 after the dose, how long will it take before you can take the second dose. The outcome of all event was outcome of unknown.  No follow-up attempts are possible. No further information is expected.
Nausea then low grade fever just before 24 hours Body aches and lack of sleep that night Chills, Headache, Backache the following night Tylenol does not help the fever. Ibuprofen helps but doesn?t last the full 6 hours
I received flu shot unusually high on left shoulder, after injection my arm was "heavy" feeling. The next week to 10 days very sore with limited use of arm. Went to Dr., then again 4 wks later because couldn't use arm, pain, limited motion, trouble dressing and sleeping from pain.
pain; slight swelling; redness; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient. A 42-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 20Oct2023 at 15:30 as dose 1, single (Batch/Lot number: unknown) at the age of 42 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "fibromyalgia" (unspecified if ongoing); "nodules on lung and thyroid" (unspecified if ongoing); "nodules on lung and thyroid" (unspecified if ongoing); "high BP" (unspecified if ongoing); "GAD" (unspecified if ongoing); "PTSD" (unspecified if ongoing); "migraines" (unspecified if ongoing); "acid reflux" (unspecified if ongoing); "sleep disorder" (unspecified if ongoing); "allergic rhinitis" (unspecified if ongoing); "anemia" (unspecified if ongoing); "asthma" (unspecified if ongoing); "OSA" (unspecified if ongoing); "OSFED" (unspecified if ongoing); "OSFED" (unspecified if ongoing); "COVID" (unspecified if ongoing), notes: prior vaccination; "Known allergies: shellfish" (unspecified if ongoing); "Known allergies: IV contrast dye" (unspecified if ongoing); "Known allergies: sensitive to gluten and iodine" (unspecified if ongoing), notes: Known allergies: sensitive to gluten and iodine. Concomitant medications included: SERTRALINE; OMEPRAZOLE; VYVANSE; WELLBUTRIN XL. Past drug history included: Iodine, reaction(s): "Known allergies: sensitive to iodine". Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 4, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 20Oct2023 at 22:00, outcome "not recovered"; ERYTHEMA (non-serious) with onset 20Oct2023 at 22:00, outcome "not recovered", described as "redness"; SWELLING (non-serious) with onset 20Oct2023 at 22:00, outcome "not recovered", described as "slight swelling". The events "pain", "slight swelling" and "redness" required physician office visit. Therapeutic measures were not taken as a result of pain, swelling, erythema.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
On Saturday he felled very tired, Monday experienced tongue numbness, and Monday experienced loss of taste.